scholarly journals SGN-CD33A (Vadastuximab Talirine) followed by Allogeneic Hematopoietic Stem Cell Transplant (AlloHSCT) Results in Durable Complete Remissions (CRs) in Patients with Acute Myeloid Leukemia (AML)

2016 ◽  
Vol 22 (3) ◽  
pp. S211-S212 ◽  
Author(s):  
Anthony S. Stein ◽  
Roland B. Walter ◽  
Anjali S. Advani ◽  
Phoenix A. Ho ◽  
Harry P. Erba
Sign in / Sign up

Export Citation Format

Share Document